Double Medical Technology released its 2026 interim report, with total operating revenue of 1.34 billion yuan, net profit attributable to the parent company of 353 million yuan, and net operating cash inflow of 276 million yuan. The company's latest asset-liability ratio is 29.92 percent, up 6.56 percentage points from the previous quarter and up 4.01 percentage points from the same period last year. Gross margin is 74.45 percent, return on equity is 10.05 percent, and diluted earnings per share is 0.86 yuan. Total asset turnover is 0.27 times, down 3.30 percent year on year, and inventory turnover is 0.27 times, down 2.14 percent year on year. The number of shareholders is 19,400, and the top ten shareholders hold 86.76 percent of the total share capital.
Double Medical Technology IncCompany reports strong interim net profit of 353 million yuan on revenue of 1.34 billion yuan.
